Dr. Larson’s academic interests include clinical trials in hematologic malignancies and stem cell transplantation, the determinants of response to therapy in leukemia and myelodysplastic syndromes and the etiology of therapy-related leukemias. He is chair of the Leukemia Committee of the Cancer and Leukemia Group B, a multicenter organization funded by the National Cancer Institute to conduct clinical trials in leukemia and other cancers.